Bioequivalence study of three ibuprofen formulations after single dose administration in healthy volunteers

BMC Pharmacology

Volumn 8, Issue , 2008, Pages

  Bramlage, Peter ^a   Goldis, Adrian ^b  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b IFE Human Pharmacology SRL   (Romania)

Author keywords

[No Author keywords available]

Indexed keywords

EUDORLIN; IBUPROFEN; MIGRANIN; UNCLASSIFIED DRUG; GENERIC DRUG;

ADULT; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET RESTRICTION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DOSAGE FORM COMPARISON; DRUG ELIMINATION; DRUG HALF LIFE; DRUG INDUCED HEADACHE; DRUG SOLUBILITY; DRUG TOLERABILITY; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MAXIMUM PLASMA CONCENTRATION; NORMAL HUMAN; OPEN STUDY; PHASE 1 CLINICAL TRIAL; PLASMA CONCENTRATION-TIME CURVE; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; TIME TO MAXIMUM PLASMA CONCENTRATION; BIOAVAILABILITY; ENTERIC COATED TABLET; PHARMACOKINETICS;

BIOLOGICAL AVAILABILITY; CROSS-OVER STUDIES; DRUGS, GENERIC; FEMALE; HUMANS; IBUPROFEN; MALE; TABLETS, ENTERIC-COATED; THERAPEUTIC EQUIVALENCY;

EID: 58149358981     PISSN: None     EISSN: 14712210     Source Type: Journal    
DOI: 10.1186/1471-2210-8-18     Document Type: Article

References (12)

1. The story of ibuprofen http://www.ibuprofen-foundation.com/
2. Frölich JC Fricker RM [Pain therapy and analgetics-antipyretics (Nonsteroidal antirheumatic drugs - NSAR)] Praktische Arzneitherapie Heidelberg: Springer Frölich JC, Kirch W 4 2006, 675-706
3. Note for Guidance on the Investigation Bioavailability and Bioequivalence (CPMP/EWP/QWP/1401/98)
4. Furey SA Waksman JA Dash BH Nonprescription ibuprofen: Side effect profile Pharmacotherapy 1992, 12(5):403-407 1437701
5. Blume H Mutschler E Bioäquivalenz, Qualitätsbewertung wirkstoffgleicher Fertigarzneimittel Frankfurt/Main - Eschborn: Govi-Verlag Pharmazeutischer Verlag 1996
6. Bienert A Szkutnik-Fiedler D Dyderski S Grzeskowiak E Drobnik L Wolc A Slawiniska U Comparative bioavailability study of two ibuprofen preparations after oral administration in healthy volunteers Arzneimittel-Forschung 2006, 56(9):647-651 17063640
7. Laska EM Sunshine A Marrero I Olson N Siegel C McCormick N The correlation between blood levels of ibuprofen and clinical analgesic response Clin Pharmacol Ther 1986, 40(1):1-7 3522030
8. Newa M Bhandari KH Kim JO Im JS Kim JA Yoo BK Woo JS Choi HG Yong CS Enhancement of solubility, dissolution and bioavailability of ibuprofen in solid dispersion systems Chem Pharm Bull (Tokyo) 2008, 56(4):569-574 18379109
9. GLP Principles of Good Laboratory Practice as specified by national (German Chemicals Law, Annex 1, 20 June 2002) and international (OECD, Paris, 1998; EC Directive 2004/10/EC, 11. February 2004)
10. U.S. Department of Health and Human Services Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CVM). Guidance for Industry Bioanalytical Method Validation http://www.fda.gov/cder/guidance/index.htm
11. Sochor J Klimes J Sedlacek J Zahradnicek M Determination of ibuprofen in erythrocytes and plasma by high performance liquid chromatography J Pharm Biomed Anal 1995, 13(7):899-903 8562614
12. SAS8.2 SAS® software Release 8.2 edition Cary NC: SAS Institute Inc 2001